Screener
Evolent Health, Inc. EVH Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Evolent Health, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Evolent Health, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:53 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628908-26-000086
| Line item | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|
| Extinguishment of Series A Preferred Stock and other refinancing fees | — | 9,000 |
| Loss on option exercise | — | 52,544 |
| Depreciation and amortization expenses | 43,121 | 47,199 |
| Stock-based compensation expense | 25,850 | 22,661 |
| Deferred tax expense | 2,970 | (570) |
| Amortization of contract cost assets | 2,023 | 2,523 |
| Amortization of deferred financing costs | 5,930 | 2,403 |
| Loss on lease termination | — | 1,906 |
Item 1. Financial Statements
FAQ
- What is Evolent Health, Inc.'s stock-based comp?
- Evolent Health, Inc. (EVH) reported stock-based comp of $15.2M in Q2 2026.
- How has Evolent Health, Inc.'s stock-based comp changed year-over-year?
- Evolent Health, Inc.'s stock-based comp increased by 31.3% year-over-year, from $11.58M to $15.2M.
- What is the long-term trend for Evolent Health, Inc.'s stock-based comp?
- Over 3 years (2021 to 2025), Evolent Health, Inc.'s stock-based comp has grown at a 33.5% compound annual growth rate (CAGR), from $16.71M to $39.74M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Evolent Health, Inc.'s stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude